Trial Profile
A Phase II Clinical Trial of Panitumumab in Combination with Infusional Oxaliplatin and Oral Capecitabine (XELOX) Chemotherapy as 1st line Therapy in Patients with Colorectal Cancer and Advanced Liver Metastases.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Sep 2015
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Oxaliplatin (Primary) ; Panitumumab (Primary)
- Indications Colorectal cancer; Liver metastases
- Focus Therapeutic Use
- 12 Sep 2015 Status changed from recruiting to completed as per European Clinical Trials Database record.
- 09 Jul 2011 New trial record